EGFR erbB1 Inhibitor
Home > PRODUCTS > Biochemicals > All Inhibitors

Diversity screening library discount

Newsletter Subscription

Stay updated with our new products and services. You can unsubscribe at any time.

EGFR erbB1 Inhibitor


Potential antibacterial agent  against the Gram-positive bacteria (MIC = 256 mg/L)


OTAVAchemicals Catalogue Number:   0107930017

CAS Registry Number:  6178-42-3

Purity: 95%


Ref.: b-Nitrostyrene derivatives as potential antibacterial agents: A structure–property–activity relationship study. Milhazes, N., Calheiros, R., Marques, M. P. M., Garrido, J., Cordeiro, M. N. D. S., Rodrigues, C., Borges, F. Bioorg. Med. Chem., 2006, 14, 4078–4088.

Abstract: A multidisciplinary project was developed, combining the synthesis of a series of b-nitrostyrene derivatives and the determination of their physicochemical parameters (redox potentials, partition coefficients), to the evaluation of the corresponding antibacterial activity. A complete conformational analysis was also performed, in order to get relevant structural information. Subsequently, a structure–property–activity (SPAR) approach was applied, through linear regression analysis, aiming at obtaining a putative correlation between the physicochemical parameters of the compounds investigated and their antibacterial activity (both against standard strains and clinical isolates). The b-nitrostyrene compounds displayed a lower activity towards all the tested bacteria relative to the b-methyl-b-nitrostyrene analogues. This was observed particularly for the 3-hydroxy-4-methoxy-b-methyl-bnitrostyrene (IVb) against the Gram-positive bacteria (Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium). The SPAR results revealed the existence of a clear correlation between the redox potentials and the antibacterial activity of the series of b-nitrostyrene derivatives under study.

DOI: 10.1016/j.bmc.2006.02.006


Price info:
1 MG 35 EUR
5 MG 49 EUR
10 MG 69 EUR
300uL of 10mM solution

39 EUR